Trial site
Hospital La Milagrosa S.A.
- 18running trials
- 8closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Epilepsy6 trials
- Narcolepsy6 trials
- Lung cancer3 trials
- Asthma2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Atrial fibrillation1 trial
- Brain metastases1 trial
- Bronchiectasis1 trial
- COPD1 trial
- Cystic fibrosis1 trial
- Head and neck cancer1 trial
- Idiopathic pulmonary fibrosis1 trial
- Phase
- Phase 313 trials
- Phase 29 trials
- Phase 2/33 trials
- Phase 1/21 trial
- Status
- Recruiting9 trials
- Completed8 trials
- Not yet recruiting5 trials
- Active, not recruiting4 trials
- Lead sponsor
- Sanofi4 trials
- Alkermes Inc.3 trials
- Anthos Therapeutics, Inc.3 trials
- Praxis Precision Medicines Inc.3 trials
- Xenon Pharmaceuticals Inc.2 trials
- and 11 more
Running trials
Not yet recruiting
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Suspended
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Recruiting
Recruiting
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy.
Recruiting
Recruiting
Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Narcolepsy6 recruiting
- Epilepsy2 recruiting
- Lung cancer2 recruiting
- Asthma1 recruiting
- Brain metastases1 recruiting
- Bronchiectasis1 recruiting
- COPD1 recruiting
- Cystic fibrosis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026